Literature DB >> 19586808

Governing stem cell banks and registries: emerging issues.

Rosario M Isasi1, Bartha M Knoppers.   

Abstract

The expansion of national and international research efforts in stem cell research is increasingly paired with the trend of establishing stem cell banks and registries. In jurisdictions crossing the spectrum of restrictive to liberal stem cell policies, banks and registries are emerging as an essential resource for transnational access to quality-controlled and ethically sourced stem cell lines. In this study, we report the preliminary findings of a survey of stem cell banks participating in the International Stem Cell Forum's International Stem Cell Banking Initiative (ISCBI). The questionnaire circulated to all ISCBI members addressed both general issues surrounding research policies (e.g., national policies regulating the permissibility of conducting embryonic stem cell research (hESCR)) and, more specifically, issues relating to the governance of stem cell banking projects. The results of the questionnaire were complemented by scholarly research conducted by the authors. This article provides an overview of the current international hESC banking landscape (I). For this purpose, the policy and governance approaches adopted in the surveyed stem cell banks at the national level will be analyzed and areas of convergence and variance will be identified (II). It is beyond the scope of this paper to provide a comprehensive analysis of the wide range of possible governance approaches, policy responses, and their implications. However, we want to provide a starting point for discussion surrounding key questions and challenges as concerns provenance, access, and deposit of hESC lines (III). Finally, while our analysis is focused on research grade hESCs, the lessons to be gleaned from this examination will encourage further thought, analysis, and research into the issues raised in the banking and governance of other sources of stem cell lines (e.g., SCNT, parthenogenesis, iPs) (IV).

Mesh:

Year:  2009        PMID: 19586808     DOI: 10.1016/j.scr.2009.05.003

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  14 in total

1.  Stem cell banking: between traceability and identifiability.

Authors:  Bartha M Knoppers; Rosario Isasi
Journal:  Genome Med       Date:  2010-10-05       Impact factor: 11.117

2.  The National Stem Cell Therapy Patient Registry of Malaysia--measuring clinical outcomes of stem cell therapy.

Authors:  Seng Cheong Loke; Sze Piaw Chin; Sarojini Sivanandam; Pik Pin Goh; Richard Kwong Fai Ng; Khay Yong Saw; Teck Onn Lim
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

3.  The DISCUSS Project: induced pluripotent stem cell lines from previously collected research biospecimens and informed consent: points to consider.

Authors:  Geoffrey P Lomax; Sara Chandros Hull; Justin Lowenthal; Mahendra Rao; Rosario Isasi
Journal:  Stem Cells Transl Med       Date:  2013-08-29       Impact factor: 6.940

4.  Human embryonic stem cell lines and their use in international research.

Authors:  Peter Löser; Jacqueline Schirm; Anke Guhr; Anna M Wobus; Andreas Kurtz
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

5.  State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding 'Rising Powers' in the global context.

Authors:  Brian Salter; Alex Faulkner
Journal:  Global Health       Date:  2011-02-24       Impact factor: 4.185

6.  From banking to international governance: fostering innovation in stem cell research.

Authors:  Rosario Isasi; Bartha M Knoppers
Journal:  Stem Cells Int       Date:  2011-09-05       Impact factor: 5.443

7.  Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis.

Authors:  Margit Rosner; Helmut Dolznig; Katharina Schipany; Mario Mikula; Oliver Brandau; Markus Hengstschläger
Journal:  Oncotarget       Date:  2011-09

Review 8.  The use of pluripotent stem cell for personalized cell therapies against neurological disorders.

Authors:  Hye-Yeong Ha; Si-Hyong Jang; Ji-Won Jung
Journal:  J Biomed Biotechnol       Date:  2011-12-13

9.  Stem cell research funding policies and dynamic innovation: a survey of open access and commercialization requirements.

Authors:  Maroussia Lévesque; Jihyun Rosel Kim; Rosario Isasi; Bartha Maria Knoppers; Aurora Plomer; Yann Joly
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

10.  Power-laws and the use of pluripotent stem cell lines.

Authors:  Bernhard M Schuldt; Anke Guhr; Michael Lenz; Sabine Kobold; Ben D MacArthur; Andreas Schuppert; Peter Löser; Franz-Josef Müller
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.